男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Asia-Pacific

Indian company launches injectable drug for severe COVID-19 patients

Xinhua | Updated: 2020-06-22 16:26
Share
Share - WeChat

MUMBAI - Indian pharmaceutical company Cipla has launched remdesivir lyophilized powder for 100mg injection to treat severe COVID-19 patients in the domestic market, a company statement said, late Sunday.

Remdesivir is a broad-spectrum antiviral medication developed by the US based biopharmaceutical company Gilead Sciences, who had extended a voluntary non-exclusive license to a handful Indian and Pakistani companies including Cipla to manufacture and market the drug.

"We have been deeply invested in exploring all possible avenues to save millions of lives impacted by COVID-19 pandemic, and this launch is a significant milestone in that direction. We will continue to collaborate with all stakeholders in the healthcare ecosystem towards providing access to such promising treatments in furtherance with our belief that no patient should be denied access to life-saving treatments," said Umang Vohra, Managing Director and Global CEO, Cipla Limited, without disclosing the pricing of the injectable drug.

Last week, another Indian company Glenmark Pharmaceuticals had launched anti-viral drug Favipiravir for the treatment of mild to moderate COVID-19 patients in the domestic market at $1.35 per tablet.

Cipla will be commercializing remdesivir through its own facilities and partnered sites and will supply the drug through government and open market channels, to ensure equitable distribution.

As on Monday morning, India, ranked fourth among all countries for confirmed COVID-19 cases, has 174,387 active cases with 13,699 deaths reported so far.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 临武县| 凌云县| 综艺| 浮梁县| 若尔盖县| 偏关县| 嫩江县| 调兵山市| 南陵县| 贵港市| 伽师县| 汝州市| 元江| 宣恩县| 内黄县| 太和县| 万安县| 嘉定区| 常熟市| 中西区| 亚东县| 广东省| 禹城市| 惠东县| 嵊泗县| 包头市| 高台县| 合山市| 永泰县| 星座| 廉江市| 门头沟区| 大埔区| 潜山县| 安宁市| 新乡县| 夏河县| 宝丰县| 拉萨市| 万源市| 丹阳市|